Title: Michael Niesman, et al. Treatment of autoimmune disease. WO2015179847A1.
1036260-25-9 | 3-Aminocyclobutanol hydrochloride | AA008TOG | MFCD12547215
104-16-5 | 1-(3-Chloropropyl)-4-methylpiperazine | AA008TY0 | MFCD06205980
1101120-37-9 | Pyrazolo[1,5-a]pyridin-5-amine | AA008U6S | MFCD11924930
1187830-46-1 | 6,7-Dihydro-5h-pyrrolo[3,4-d]pyrimidine, HCl | AA008UG3 | MFCD11846189
102782-97-8 | EPOXYPROPOXYPROPYL TERMINATED POLYDIMETHYLSILOXANE | AA008UQY | MFCD00283171
1142211-15-1 | 2,4-Dihydroxy-3-methylbenzohydrazide | AA008V19 | MFCD12028428
108957-96-6 | N-Isopropyl-n-methylglycine | AA008V79 | MFCD09864552
1146299-25-3 | 4,5-dimethyl-2-(1H-tetrazol-1-yl)-3-thiophenecarboxylic acid | AA008VCO | MFCD11868490
1018295-15-2 | [(3,5-Dimethylphenyl)amino](oxo)acetic acid | AA008VI2 | MFCD10018452
112163-39-0 | 7-CYANOMETHOTREXATE DIMETHYL ESTER | AA008VO0 | MFCD09840284